IBO
AMEX · Pharmaceuticals
Impact Biomedical Inc
$0.63
-0.01 (-1.24%)
Open$0.61
Previous Close$0.64
Day High$0.64
Day Low$0.60
52W High$1.95
52W Low$0.36
Volume—
Avg Volume58.9K
Market Cap65.61M
P/E Ratio—
EPS$-1.34
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 104.6K | 2.01M | 2.09M |
| Net Income | -39,253,882 | 252.5K | 255.6K |
| Profit Margin | -36,993.8% | 12.5% | 12.2% |
| EBITDA | -10,399,349 | 413.4K | 402.4K |
| Free Cash Flow | — | 302.8K | 206.2K |
| Rev Growth | — | +12.9% | +6.5% |
| Debt/Equity | 0.05 | 0.52 | 0.58 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |